Status:
COMPLETED
Study of T-PRED(TM) Compared to Pred Forte(R) II
Lead Sponsor:
Bausch & Lomb Incorporated
Conditions:
Cataract
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Study of T-PRED(TM) Compared to Pred Forte(R)
Detailed Description
This study was a multi-center, randomized, double-masked, bioequivalence study. A total of 172 participants undergoing bilateral cataract surgery were assigned investigational product to each eye acco...
Eligibility Criteria
Inclusion
- 18 years of age or older
Exclusion
- No active or adverse disease
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
172 Patients enrolled
Trial Details
Trial ID
NCT00854061
Start Date
February 1 2009
End Date
August 1 2009
Last Update
October 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISTA Pharmaceuticals, Inc.
Irvine, California, United States, 92618